Get notified when CATX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: CATX Perspective Therapeutics, Inc. 8-K

Perspective Therapeutics to present interim clinical trial results at ASCO 2026

Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read

Key Changes

  • medium

    Company announced interim results from ongoing clinical trials will be presented at the American Society of Clinical Oncology Annual Meeting, May 29-June 2, 2026 in Chicago. Actual trial data not disclosed in the 8-K filing.

  • medium

    Press release issued May 21, 2026 contains the full details of the interim results being presented at ASCO.

    Exhibit 99.1 verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.

Partner

Trade CATX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · May 24, 2026 · How we verify